Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 1,705–1,712 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Evommune Inc. EVO301 Ulcerative Colitis Phase 2 Trial Planned Intravenous Gastroenterology
Evommune Inc. EVO756 Atopic Dermatitis Phase 2b Ongoing Inhalation Immunology
Evommune Inc. EVO756 Chronic Spontaneous Urticaria Phase 2b Ongoing Inhalation Immunology
Evommune Inc. EVO301 Atopic Dermatitis Phase 2a Ongoing Intravenous Immunology
Evotec SE BAY 3401016 - (ASSESS) Alport Syndrome Phase 2a Enrollment Initiation oral Genetic Disorder
Exelixis Inc. Cabozantinib w/ pembrolizumab Recurrent or metastatic head and neck cancer Phase 2 Trial Completed Oral with intravenous Oncology
Exelixis Inc. Zanzalintinib - (STELLAR-304) Advanced non-clear cell renal cell carcinoma (nccRCC) Phase 3 Ongoing Oral Oncology
Exelixis Inc. Zanzalintinib - (STELLAR-304) Advanced non-clear cell renal cell carcinoma (nccRCC) Phase 3 Ongoing Oral Oncology